NCT03330392已完成不适用
An 8 Week, Randomized, Double-blind, Placebo-controlled Clinical Trial of AGP on Immune Enhancing Effects
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 80
- 试验地点
- 2
- 主要终点
- Natural killer cell activity
研究概览
简要总结
The researchers investigated the immune enhancing effects of AGP for Korean participants.
详细描述
The aim of the study is to investigate the effects of AGP on immune enhancement based on 8 week, randomized, double-blind, placebo-controlled clinical trial.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 20 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •The levels of white blood cells within range 3x10^3/μL~8x10^3/μL
- •have had at least two cold in the last 12 months.
排除标准
- •subjects with BMI<18.5 kg/m^2
- •subjects taking medications such as immune related drug or functional foods
- •history of disease that could interfere with the test products or impede their absorption
- •pregnant or lactating women and heavy smokers.
- •being judged by the responsible physician of the local study center as unfit to participate in the study
结局指标
主要结局
Natural killer cell activity
时间窗: 0 week, 8 week
Changes of NK cell activity were assessed before and after the intervention.
次要结局
- Interferon-γ (IFN-γ)(0 week, 8 week)
- Interleukin-1β(0 week, 8 week)
- Interleukin-6(0 week, 8 week)
- Interleukin-12 (IL-12)(0 week, 8 week)
- Tumor necrosis factor-α (TNF-α)(0 week, 8 week)
- Changes of White blood cell (WBC)(0 week, 8 week)
研究者
Soo-Wan Chae
Principal Investigator, Clinical Trial Center for Functional Foods
Chonbuk National University Hospital
研究点 (2)
Loading locations...
相似试验
已完成
不适用
The Efficacy and Safety of SGF200 on Immune EnhancementImmunityNCT04930640Chonbuk National University Hospital100
已完成
不适用
Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical PatientsImmunityNCT01885728Martin Angst22
已完成
1 期
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral DensityOsteopeniaNCT01101048Amgen74
已完成
2 期
To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory AllergiesMild Asthma and Allergic RhinitisNCT01788813GlaxoSmithKline42
终止
2 期
Safety and Efficacy Study of MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After CystectomyUrinary Bladder NeoplasmsNCT01435356European Association of Urology Research Foundation83
